Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

被引：0
|
作者：
C Preisinger
J P Schwarz
O B Bleijerveld
E Corradini
P J Müller
K I Anderson
W Kolch
A Scholten
A J R Heck
机构：
[1] Biomolecular Mass Spectrometry and Proteomics Group,Department of Biochemistry
[2] Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences,undefined
[3] Utrecht University,undefined
[4] Netherlands Proteomics Centre,undefined
[5] The Beatson Institute for Cancer Research,undefined
[6] Garscube Estate,undefined
[7] RWTH Aachen University,undefined
[8] Systems Biology Ireland,undefined
[9] University College Dublin,undefined
[10] Belfield,undefined
[11] Centre for Biomedical Genetics,undefined
[12] 7Current address: Proteomics Facility,undefined
[13] Interdisciplinary Centre for Clinical Research (IZKF) Aachen,undefined
[14] RWTH Aachen University,undefined
[15] Aachen,undefined
[16] Germany.,undefined
来源：
Leukemia | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：743 / 746
页数：3
相关论文
共 50 条
  • [1] Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells
    Preisinger, C.
    Schwarz, J. P.
    Bleijerveld, O. B.
    Corradini, E.
    Mueller, P. J.
    Anderson, K. I.
    Kolch, W.
    Scholten, A.
    Heck, A. J. R.
    LEUKEMIA, 2013, 27 (03) : 743 - 746
  • [2] Monitoring minimal residual disease in BCR-ABL-positive chronic myeloid leukemia in the imatinib era
    Goldman, J
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 33 - 39
  • [3] Detection of BCR-ABL-Positive Cells in the Colostrum of a Pregnant Patient with Chronic Myeloid Leukemia
    Hiroshima, Yuki
    Tajima, Katsushi
    Shiono, Yousuke
    Suzuki, Ikuko
    Kouno, Kei
    Katou, Yuuichi
    Kato, Takeo
    INTERNAL MEDICINE, 2011, 50 (20) : 2389 - 2391
  • [4] Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia
    Thijsen, SFT
    vanOostveen, JW
    Schuurhuis, GJ
    Theijsmeijer, AP
    Oudejans, CBM
    vanWijk, IJ
    Langenhuijsen, MMAC
    Ossenkoppele, GJ
    LEUKEMIA, 1997, 11 (10) : 1762 - 1768
  • [5] Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells
    Tauchi, T
    Nakajima, A
    Sashida, G
    Shimamoto, T
    Ohyashiki, JH
    Abe, K
    Yamamoto, K
    Ohyashiki, K
    CLINICAL CANCER RESEARCH, 2002, 8 (11) : 3341 - 3347
  • [6] Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia
    SFT Thijsen
    JW van Oostveen
    GJ Schuurhuis
    AP Theijsmeijer
    CBM Oudejans
    IJ van Wijk
    MMAC Langenhuijsen
    GJ Ossenkoppele
    Leukemia, 1997, 11 : 1762 - 1768
  • [7] NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice
    Chen, Ci-U
    Koschmieder, S.
    Kerstiens, L.
    Schemionek, M.
    Altvater, B.
    Pscherer, S.
    Gerss, J.
    Maecker, H. T.
    Berdel, W. E.
    Juergens, H.
    Lee, P. P.
    Rossig, C.
    LEUKEMIA, 2012, 26 (03) : 465 - 474
  • [8] The Proteolytic Activity of Separase in BCR-ABL-Positive Cells Is Increased by Imatinib
    Haass, Wiltrud
    Stehle, Michael
    Nittka, Stefanie
    Giehl, Michelle
    Schrotz-King, Petra
    Fabarius, Alice
    Hofmann, Wolf-Karsten
    Seifarth, Wolfgang
    PLOS ONE, 2012, 7 (08):
  • [9] 3′ BCR recombines with IGL locus in BCR-ABL-positive philadelphia-negative chronic myeloid leukemia
    Benjes, SM
    Millow, LJ
    Jeffs, AR
    Sowerby, SJ
    Reeve, AE
    Morris, CM
    GENES CHROMOSOMES & CANCER, 1999, 26 (04): : 366 - 371
  • [10] The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells
    Baran, Y.
    Kosova, B.
    Tezcanli, B.
    Ekiz, H. A.
    Cakir, Z.
    Selvi, N.
    EJC SUPPLEMENTS, 2010, 8 (05): : 52 - 53
12345